摘要
Abstract(#br)Background & Aim(#br)The need for a subclassification of Barcelona Clinic Liver Cancer ( BCLC ) intermediate‐stage ( BCLC B) has arisen because of its diversity. We evaluated the prognostic capability of the BCLC B subclassification proposed by Bolondi et al. in patients treated with tr...